Advertisement

Topics

Esperion Announces Positive Top-Line Results From Phase II Study Of Bempedoic Acid / Ezetimibe Combination Plus Atorvastatin

20:00 EDT 7 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Esperion Announces Positive Top-Line Results From Phase II Study Of Bempedoic Acid / Ezetimibe Combination Plus Atorvastatin

NEXT ARTICLE

More From BioPortfolio on "Esperion Announces Positive Top-Line Results From Phase II Study Of Bempedoic Acid / Ezetimibe Combination Plus Atorvastatin"

Quick Search
Advertisement